Romosozumab Treatment in Postmenopausal Osteoporosis

Affiliations

Comment

Felicia Cosman et al. N Engl J Med. 2017.

. 2017 Jan 26;376(4):396-7.

doi: 10.1056/NEJMc1615367.

No abstract available

Comment on

Romosozumab Treatment in Postmenopausal Women with Osteoporosis.
Cosman F, Crittenden DB, Adachi JD, Binkley N, Czerwinski E, Ferrari S, Hofbauer LC, Lau E, Lewiecki EM, Miyauchi A, Zerbini CA, Milmont CE, Chen L, Maddox J, Meisner PD, Libanati C, Grauer A. Cosman F, et al. N Engl J Med. 2016 Oct 20;375(16):1532-1543. doi: 10.1056/NEJMoa1607948. Epub 2016 Sep 18. N Engl J Med. 2016. PMID: 27641143 Clinical Trial.
Romosozumab Treatment in Postmenopausal Osteoporosis.
Kranenburg G, Bartstra JW, de Jong PA. Kranenburg G, et al. N Engl J Med. 2017 Jan 26;376(4):396. doi: 10.1056/NEJMc1615367. N Engl J Med. 2017. PMID: 28121505 No abstract available.
Romosozumab Treatment in Postmenopausal Osteoporosis.
Sharma R, Torka P. Sharma R, et al. N Engl J Med. 2017 Jan 26;376(4):395. doi: 10.1056/NEJMc1615367. N Engl J Med. 2017. PMID: 28125190 No abstract available.
Romosozumab Treatment in Postmenopausal Osteoporosis.
Banhidy NF, MacKinnon TS, Banhidy FP. Banhidy NF, et al. N Engl J Med. 2017 Jan 26;376(4):395. doi: 10.1056/NEJMc1615367. N Engl J Med. 2017. PMID: 28125191 No abstract available.
Romosozumab Treatment in Postmenopausal Osteoporosis.
Kalyan S. Kalyan S. N Engl J Med. 2017 Jan 26;376(4):395-6. doi: 10.1056/NEJMc1615367. N Engl J Med. 2017. PMID: 28125192 No abstract available.